BPC-157 is used as an adjunct, not a replacement, for standard post-op care
See whats possible
Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia
These include GLP-1R agonists [36,37,38], Type 2 sodium-glucose cotransporter (SGLT2) inhibitors (which, although associated with weight loss in people with type 2 diabetes due to their mechanism of action, are not generally considered anti-obesity drugs) [39,40,41], sympathomimetics [42, 43], serotoninergic system drugs [44,45,46], opioid receptor antagonists/weak inhibitor of neuronal dopamine and norepinephrine reuptake inhibitors [47, 48], and pancreatic lipase inhibitors [49, 50] (Fig
This guide explains how the treatment works, what it helps with, and what to expect when you come in